BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29473291)

  • 1. Bayesian approach for assessing noninferiority in a three-arm trial with binary endpoint.
    Ghosh S; Tiwari RC; Ghosh S
    Pharm Stat; 2018 Jul; 17(4):342-357. PubMed ID: 29473291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian approach for assessing non-inferiority in a three-arm trial with pre-specified margin.
    Ghosh S; Ghosh S; Tiwari RC
    Stat Med; 2016 Feb; 35(5):695-708. PubMed ID: 26434554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian approach to noninferiority trials for proportions.
    Gamalo MA; Wu R; Tiwari RC
    J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches for testing noninferiority in two-arm trials for risk ratio and odds ratio.
    Chowdhury S; Tiwari RC; Ghosh S
    J Biopharm Stat; 2019; 29(3):425-445. PubMed ID: 30744476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
    Hida E; Tango T
    J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.
    Liu GF
    Pharm Stat; 2018 Feb; 17(1):61-73. PubMed ID: 29125220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches for testing non-inferiority for three-arm trials with Poisson distributed outcomes.
    Ghosh S; Paul E; Chowdhury S; Tiwari RC
    Biostatistics; 2022 Jan; 23(1):136-156. PubMed ID: 32385495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test.
    Doi M; Takahashi F; Kawasaki Y
    Stat Med; 2017 Dec; 36(30):4789-4803. PubMed ID: 28960376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian Approach for Assessing Non-inferiority in Three-arm Trials for Risk Ratio and Odds Ratio.
    Chowdhury S; Tiwari RC; Ghosh S
    Stat Biopharm Res; 2019; 11(1):34-43. PubMed ID: 31602287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian methods for the design and analysis of noninferiority trials.
    Gamalo-Siebers M; Gao A; Lakshminarayanan M; Liu G; Natanegara F; Railkar R; Schmidli H; Song G
    J Biopharm Stat; 2016; 26(5):823-41. PubMed ID: 26247350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A more powerful test for three-arm non-inferiority via risk difference: Frequentist and Bayesian approaches.
    Paul E; Tiwari RC; Chowdhury S; Ghosh S
    J Appl Stat; 2023; 50(4):848-870. PubMed ID: 36925904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninferiority hypotheses and choice of noninferiority margin.
    Ng TH
    Stat Med; 2008 Nov; 27(26):5392-406. PubMed ID: 18680173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulation optimization for Bayesian multi-arm multi-stage clinical trial with binary endpoints.
    Yu Z; Ramakrishnan V; Meinzer C
    J Biopharm Stat; 2019; 29(2):306-317. PubMed ID: 30763151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Likelihood ratio and a Bayesian approach were superior to standard noninferiority analysis when the noninferiority margin varied with the control event rate.
    Kim MY; Xue X
    J Clin Epidemiol; 2004 Dec; 57(12):1253-61. PubMed ID: 15617951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variance prior specification for a basket trial design using Bayesian hierarchical modeling.
    Cunanan KM; Iasonos A; Shen R; Gönen M
    Clin Trials; 2019 Apr; 16(2):142-153. PubMed ID: 30526008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables.
    Jiang Z; Song Y; Shou Q; Xia J; Wang W
    Trials; 2014 Dec; 15():500. PubMed ID: 25528466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous confidence interval for assessing non-inferiority with assay sensitivity in a three-arm trial with binary endpoints.
    Tang N; Yu B
    Pharm Stat; 2020 Sep; 19(5):518-531. PubMed ID: 32112669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian design and analysis of composite endpoints in clinical trials with multiple dependent binary outcomes.
    Zaslavsky BG
    Pharm Stat; 2013; 12(4):207-12. PubMed ID: 23625660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiparametric bayesian testing procedure for noninferiority trials with binary endpoints.
    Osman M; Ghosh SK
    J Biopharm Stat; 2011 Sep; 21(5):920-37. PubMed ID: 21830923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
    Hung HM; Wang SJ; O'Neill R
    J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.